| P2093 | author name string | Safia Awan | |
| | Mohammad Wasay | |
| | Ehsan Ullah Syed | |
| P2860 | cites work | A rating scale for depression | Q24564540 |
| | High vitamin B12 level and good treatment outcome may be associated in major depressive disorder | Q24805416 |
| | Folate, vitamin B12, and homocysteine in major depressive disorder. | Q55066928 |
| | Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians | Q74258057 |
| | Total plasma homocysteine, folate, and vitamin B12 status in healthy Iranian adults: the Tehran homocysteine survey (2003-2004)/a cross-sectional population based study | Q25257434 |
| | Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors | Q32069179 |
| | Vitamin B12 deficiency | Q34184364 |
| | Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study | Q34529325 |
| | Homocysteine, folate, methylation, and monoamine metabolism in depression | Q35458595 |
| | Risk factors, prevalence, and treatment of anxiety and depressive disorders in Pakistan: systematic review | Q35740618 |
| | The art of prescribing. Monotherapy antidepressant: a thing of the past? Implications for the treatment of major depressive disorder | Q36852137 |
| | Vitamin B12 deficiency and hyperhomocysteinemia in rural and urban Indians. | Q39781299 |
| | Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability. | Q41528264 |
| | Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety. | Q42694733 |
| | Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression | Q44015738 |
| | Plasma total homocysteine, folate, and vitamin B12 status in Korean adults. | Q44254375 |
| | Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression | Q45026425 |
| | Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy | Q45026428 |
| | Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample | Q46459790 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | major depressive disorder | Q42844 |
| | vitamin B12 | Q187706 |
| | vitamin B | Q183206 |
| P304 | page(s) | 44-48 | |
| P577 | publication date | 2013-11-15 | |
| P1433 | published in | The open neurology journal | Q27722068 |
| P1476 | title | Vitamin B12 supplementation in treating major depressive disorder: a randomized controlled trial | |
| P478 | volume | 7 | |